Kidney (Renal Cell) Cancer—Health Professional Version

Get detailed information about the treatment of newly diagnosed and recurrent renal cell cancer in this summary for clinicians.

Get detailed treatment information for newly diagnosed and recurrent disease in this clinician summary.

Get detailed information about the treatment for newly diagnosed and recurrent Wilms and other kidney tumors in this summary for clinicians.

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for kidney cancer. The list includes generic names and brand names.

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for Wilms tumor and other childhood kidney cancers. The list includes generic names and brand names.

Get comprehensive information on hereditary cancer syndromes in this clinician summary.

This evidence-based, expert-reviewed summary discusses von Hippel-Lindau disease (VHL), including the VHL gene, screening, clinical presentation, management, and prognosis.

Evidence-based, expert-reviewed summary about hereditary leiomyomatosis and renal cell cancer (HLRCC), including information about the FH gene.

Evidence-based, expert-reviewed summary about the hereditary papillary renal carcinoma (HPRC), including information about the MET gene.

This evidence-based, expert-reviewed summary discusses Birt-Hogg-Dubé syndrome (BHD), including the FLCN gene, screening, clinical presentation, management, and prognosis.

This evidence-based, expert-reviewed summary discusses rhabdoid tumor predisposition syndrome type 1 (RTPS1), including the SMARCB1 gene, clinical features, and management.